Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
GT Biopharma Inc. OXIS
Posted On: 03/10/2014 10:37:53 PM
Post# of 325
Avatar
Posted By: Stock_Tracker
Latest Oxis Intl Inc (OXIS) Headlines



Cardiovascular Disease - Pipeline Review: Latest updates and review of key players

M2 - Wed Jan 09, 5:00AM CST

Research and Markets (http://www.researchandmarkets.com/research/9szlks/cardiovascular) has announced the addition of Global Markets Direct's new report "Cardiovascular Disease - Pipeline Review, H2 2012" to their offering. This report provides information on the therapeutic development for Cardiovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Disease. Cardiovascular Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Cardiovascular Disease. - A review of the Cardiovascular Disease products under development by














(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site